Devices
FDA Seeks Advisory Panel Input on Galleri Cancer Screening Test
FDA is seeking advisory committee input on 9/23 on the benefits and risks of GRAIL's Galleri multi-cancer early detection test after two pivotal studies showed that the blood-based screening test detected about one-third of cancers diagnosed within 12 months of testing. In an executive